EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Acinetobacter baumannii Clinical Isolates Resist Complement-Mediated Lysis by Inhibiting the Complement Cascade and Improperly Depositing MAC

Michal Magda, Wendy Boschloo, Serena Bettoni, Derek Fairley, Thomas A Russo, Christian G Giske, Chaitanya Tellapragada, Suzan H M Rooijakkers, Kristian Riesbeck, Anna M Blom

Journal of Innate Immunity · 2025

DOI: 10.1159/000543664 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Innate Immunity, 2025. Verfasst von Michal Magda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, Lund University, Malmö, Sweden. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Acinetobacter Infections, Complement Membrane Attack Complex, Complement System Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Acinetobacter baumannii is a gram-negative opportunistic bacterium that causes life-threatening infections in immunocompromised hosts. The complement system is a critical mechanism of innate immunity that protects the human body from bacterial infections. Complement activation leads to the deposition of the membrane attack complex (MAC), which can directly lyse gram-negative bacteria. However, A. baumannii has developed evasion mechanisms to protect itself from complement.

Methods

Complement deposition was investigated by flow cytometry and Western blotting. Soluble MAC formation was assessed by ELISA. Bacterial serum resistance was determined by the SYTOX Green Assay. Galleria mellonella was used as an infection model. Genome sequencing revealed virulence genes carried by isolates.

Results

We examined clinical isolates of A. baumannii and found 11 isolates with MAC deposition and 5 isolates without deposition. Trypsinization of MAC-positive isolates significantly reduced MAC, indicating incorrect insertion, consistent with a lack of lysis of these strains. MAC-negative isolates inhibited alternative pathway activation and were significantly more serum-resistant. These strains were also more virulent in a G. mellonella infection model. Whole genome sequencing revealed that MAC-negative isolates carried more virulence genes, and both MAC-negative and MAC-positive A. baumannii significantly differed in capsule type. Importantly, a correlation was observed between complement inhibition and capsule type (e.g., capsule locus KL171) of MAC-negative bacteria, while the capsule type (e.g., KL230) of MAC-positive A. baumannii was associated with increased sensitivity to MAC-mediated lysis.

Conclusion

Our findings suggest a relationship between capsule type, complement resistance, and host virulence in A. baumannii.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiAcinetobacter InfectionsComplement Membrane Attack ComplexComplement System ProteinsAnimalsHumansComplement ActivationMothsVirulenceImmune EvasionImmunity, InnateVirulence Factors

Stichwörter der Autor:innen

Acinetobacter baumanniiComplement systemEvasion mechanismGalleria mellonellaMembrane attack complex

Substanzen

Complement Membrane Attack ComplexComplement System ProteinsVirulence Factors

Autor:innen und Institutionen

  • Department of Translational Medicine, Lund University, Malmö, Sweden.
  • Department of Microbiology, Belfast Health and Social Care Trust, Belfast, UK.
  • Veterans Administration Western New York Healthcare System, Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University Buffalo, Buffalo, New York, USA.
  • Department of Laboratory Medicine, Karolinska Institute, Solna, Sweden.
  • Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Förderung

  • BLRD VA

Zitieren

APA

Magda, M., Boschloo, W., Bettoni, S., Fairley, D., Russo, T. A., Giske, C. G., Tellapragada, C., Rooijakkers, S. H. M., Riesbeck, K., & Blom, A. M. (2025). Acinetobacter baumannii Clinical Isolates Resist Complement-Mediated Lysis by Inhibiting the Complement Cascade and Improperly Depositing MAC. Journal of Innate Immunity. https://doi.org/10.1159/000543664

Vancouver

Magda M, Boschloo W, Bettoni S, Fairley D, Russo TA, Giske CG, et al. Acinetobacter baumannii Clinical Isolates Resist Complement-Mediated Lysis by Inhibiting the Complement Cascade and Improperly Depositing MAC. Journal of Innate Immunity. 2025. doi:10.1159/000543664

BibTeX
@article{Magda2025,
  author = {Magda, Michal and Boschloo, Wendy and Bettoni, Serena and Fairley, Derek and Russo, Thomas A and Giske, Christian G and Tellapragada, Chaitanya and Rooijakkers, Suzan H M and Riesbeck, Kristian and Blom, Anna M},
  title = {Acinetobacter baumannii Clinical Isolates Resist Complement-Mediated Lysis by Inhibiting the Complement Cascade and Improperly Depositing MAC},
  journal = {Journal of Innate Immunity},
  year = {2025},
  doi = {10.1159/000543664}
}
Kostenlos starten →